Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Inventory (2016 - 2026)

Conmed filings provide 17 years of Inventory readings, the most recent being $366.1 million for Q1 2026.

  • On a quarterly basis, Inventory rose 3.22% to $366.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $366.1 million, a 3.22% increase, with the full-year FY2025 number at $355.5 million, up 2.55% from a year prior.
  • Inventory hit $366.1 million in Q1 2026 for Conmed, up from $355.5 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $366.1 million in Q1 2026 to a low of $253.7 million in Q1 2022.
  • Median Inventory over the past 5 years was $332.3 million (2022), compared with a mean of $330.8 million.
  • Biggest five-year swings in Inventory: surged 43.46% in 2022 and later fell 4.21% in 2023.
  • Conmed's Inventory stood at $332.3 million in 2022, then fell by 4.21% to $318.3 million in 2023, then increased by 8.92% to $346.7 million in 2024, then increased by 2.55% to $355.5 million in 2025, then increased by 2.97% to $366.1 million in 2026.
  • The last three reported values for Inventory were $366.1 million (Q1 2026), $355.5 million (Q4 2025), and $364.4 million (Q3 2025) per Business Quant data.